Patten Darren K, Ahmed Alia, Greaves Owain, Dina Roberto, Flora Rashpal, Tolley Neil
Department of Surgery, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
Department of Surgery and Cancer, The Imperial Centre for Translational and Experimental Medicine, Imperial College London, Hammersmith Campus, London, UK.
Case Rep Endocrinol. 2017;2017:4581626. doi: 10.1155/2017/4581626. Epub 2017 Apr 6.
Tall cell variant (TCV) of papillary thyroid carcinoma (PTC), an aggressive form of thyroid cancer, is characterised by 50% of cells with height that is three times greater than the width. Very rarely, some of these cancers can progress to spindle cell squamous carcinoma (SCSC) resulting in cancers with elements of both SCSC and TCV PTC. Here we report a case of SCSC arising from TCV PTC. In addition to this case, we have performed a literature review and compiled all published reports of SCSC arising from TCV PTC, including the nature of treatment and the prognosis for each of the 20 patients recorded. This is intended for use as a guide for clinicians in what the most appropriate treatment options may be for a newly diagnosed patient. Due to the rarity coupled with diagnosis occurring at a very advanced stage of disease progression, performing clinical trials is difficult and therefore drawing conclusions on optimal treatment methods remains a challenge.
甲状腺乳头状癌(PTC)的高细胞变体(TCV)是一种侵袭性甲状腺癌,其特征是50%的细胞高度大于宽度的三倍。非常罕见的是,其中一些癌症会进展为梭形细胞鳞状癌(SCSC),导致癌症同时具有SCSC和TCV PTC的成分。在此,我们报告一例由TCV PTC引发的SCSC病例。除该病例外,我们还进行了文献综述,并汇编了所有已发表的由TCV PTC引发的SCSC报告,包括20例记录患者的治疗性质和预后情况。这旨在为临床医生提供指导,以便为新诊断患者选择最合适的治疗方案。由于该病罕见且诊断往往发生在疾病进展的非常晚期阶段,开展临床试验很困难,因此就最佳治疗方法得出结论仍然是一项挑战。